Nature Publishes Preclinical Data on an Inhibitor of a Novel Target Discovered by Takeda Pharmaceutical Co. Ltd.

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Takeda Pharmaceutical Company and Millennium: The Takeda Oncology Company today announced publication of an article describing the discovery of MLN4924—a small molecule inhibitor of the NEDD8-Activating Enzyme (NAE) in the journal Nature.